416 results on '"Psaila, Bethan"'
Search Results
2. Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution
3. Shaping hematopoietic cell ecosystems through galectin-glycan interactions
4. Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients
5. Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021
6. Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies
7. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
8. Single-cell methods in myeloproliferative neoplasms: old questions, new technologies
9. In utero origin of myelofibrosis presenting in adult monozygotic twins
10. Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
11. CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies
12. HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression
13. Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro
14. Correction: Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients
15. Pre-metastatic niches: organ-specific homes for metastases.
16. Artificial intelligence–based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patients
17. Turn It Off! Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms
18. Sending the Right Message: Optimizing Cytokine-receptor Signaling for Therapeutic Impact
19. Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A
20. Platelets Sequester Extracellular DNA, Capturing Tumour-Derived and Free Fetal DNA
21. Multiparametric MRI detects multi-organ impairment in patients with chronic myeloid neoplasms with normal serum biomarkers.
22. Outcomes and Characteristics of Non-Melanoma Skin Cancers in Patients with Myeloproliferative Neoplasms on Ruxolitinib
23. Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs
24. Biology of paediatric leukaemia.
25. Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues
26. A pro-inflammatory stem cell niche drives myelofibrosis through a targetable galectin 1 axis
27. Interactions between megakaryocytes and tumour cells in the bone marrow vascular stem cell niche promote tumour growth and metastasis
28. Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator
29. The management of myelofibrosis: A British Society for Haematology Guideline.
30. Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.
31. Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib
32. Data from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
33. Supp Table 1 from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
34. Supp Table 2 from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
35. Supp Table 3 from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
36. Supp Table 4 from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
37. Supp Table 5 from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
38. Supplementary Information from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
39. Inflammatory Monocytes: Fanning the Flames of Clonal Hematopoiesis
40. MAC-Attack! Unpacking Responses to Venetoclax with Azacitidine
41. In Myelofibrosis, Is It the Megs or the Tregs?
42. 3031 – CHROMOTHRIPSIS AND LEUKEMIC TRANSFORMATION IN MPN
43. The Clocks Start Ticking Earlier Than We Thought
44. Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients
45. Disease Characteristics and Outcomes of Non-Melanoma Skin Cancers in Myeloproliferative Neoplasm (MPN) Patients Treated with Ruxolitinib
46. Cross-Talk between Hematopoietic Cells and Fibroblast Subsets Drives Inflammation and Remodelling of the Bone Marrow Microenvironment in Myeloproliferative Neoplasms
47. Single-Cell Transcriptome Analysis Reveals Pathways That Drive Dyserythropoiesis in Myelodysplastic Syndromes, Which Are Targeted By Luspatercept
48. Quantitative MRI Detects Multi-Organ Impairment in Patients with Chronic Myeloid Neoplasms
49. Human Bone Marrow Organoids Enable the Study of Hematopoietic Cell-Stromal Interactions and Support the Survival of Malignant Cells from Patients
50. The Use of Avapritinib in Advanced Systemic Mastocytosis: Report of an Open-Label Compassionate Use Program in the United Kingdom
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.